Yaw Nyame
@yawnyame.bsky.social
Associate Professor, Urologic Oncologist at University of Washington, Fred Hutch. Health and equity advocate. Food, music, sports (Boomer Sooner) and ski lover.
Kicked off our 3rd and final day with the YUO program and a fantastic lecture by Dr. Christopher Kane.
Congratulations to Dr. Kane on being the Joseph A Smith Jr Mentorship award recipient #SUO24
Congratulations to Dr. Kane on being the Joseph A Smith Jr Mentorship award recipient #SUO24
December 6, 2024 at 3:35 PM
Kicked off our 3rd and final day with the YUO program and a fantastic lecture by Dr. Christopher Kane.
Congratulations to Dr. Kane on being the Joseph A Smith Jr Mentorship award recipient #SUO24
Congratulations to Dr. Kane on being the Joseph A Smith Jr Mentorship award recipient #SUO24
Lastly the SUO-CTC is doing very well paving the way for successful clinical trial participation in our society improving therapeutic options for our patients. Congratulations to the CTC committee led by Viraj Masters #SUO24
December 6, 2024 at 2:30 PM
Lastly the SUO-CTC is doing very well paving the way for successful clinical trial participation in our society improving therapeutic options for our patients. Congratulations to the CTC committee led by Viraj Masters #SUO24
Our EAU guest lecture from Tobias Nodstrom highlighting the efficacy of PSA screening and more importantly the role of MRI and biomarkers in reducing cancer overdetection! #SUO24
December 6, 2024 at 2:30 PM
Our EAU guest lecture from Tobias Nodstrom highlighting the efficacy of PSA screening and more importantly the role of MRI and biomarkers in reducing cancer overdetection! #SUO24
Sarah Psutka @fredhutch.bsky.social took us through the management of decision regret among our oncology patients. We need better decision support for our patients #SUO24
December 6, 2024 at 2:30 PM
Sarah Psutka @fredhutch.bsky.social took us through the management of decision regret among our oncology patients. We need better decision support for our patients #SUO24
Important discussion around when and how to treat low testosterone in prostate cancer patients and tech update in prostate cancer detection and treatment (AI, remote surgery) by @anobel.bsky.social #johndavis and others
December 6, 2024 at 2:30 PM
Important discussion around when and how to treat low testosterone in prostate cancer patients and tech update in prostate cancer detection and treatment (AI, remote surgery) by @anobel.bsky.social #johndavis and others
Day 2 highlights from #SUO24. We covered trial design for BCG unresponsive bladder cancer with @joshmeeks.bsky.social, upfront cystectomy in high-risk NMIBC with @vikramnarayan.bsky.social #vigneshpackiam & late breaking abstract on exciting intravesical chemo+immuno for high grade NMIBC
December 6, 2024 at 2:30 PM
Day 2 highlights from #SUO24. We covered trial design for BCG unresponsive bladder cancer with @joshmeeks.bsky.social, upfront cystectomy in high-risk NMIBC with @vikramnarayan.bsky.social #vigneshpackiam & late breaking abstract on exciting intravesical chemo+immuno for high grade NMIBC
Some troubling epi stats presented today on worsening racial disparities in testicular cancer with increasing incidence among Hispanic males and poor survival among Black males #SUO24 #testiscancer
December 5, 2024 at 4:46 PM
Some troubling epi stats presented today on worsening racial disparities in testicular cancer with increasing incidence among Hispanic males and poor survival among Black males #SUO24 #testiscancer
Sam Funt with awesome presentation of testis cancer masqueraders on imaging this morning #SUO24 #testiscancer
December 5, 2024 at 4:40 PM
Sam Funt with awesome presentation of testis cancer masqueraders on imaging this morning #SUO24 #testiscancer
Kicking off day 2 with kidney cancer session. First two talks focused on improved nuclear imaging and AI for improving cancer detection. Anyone using girentuximab in their practice? #AI #brianschuch #nicholaskavoussi #SUO24
December 5, 2024 at 2:28 PM
Kicking off day 2 with kidney cancer session. First two talks focused on improved nuclear imaging and AI for improving cancer detection. Anyone using girentuximab in their practice? #AI #brianschuch #nicholaskavoussi #SUO24
Major change in metastatic seminoma management. Who is using RPLND to manage stage IIA/B at their institutions? What is your criteria for patient selection? How do you balance decision with other effective options (chemo/rads)? #SUO24 #richmatulewicz #timmasterson @samfunt.bsky.social
December 4, 2024 at 9:47 PM
Major change in metastatic seminoma management. Who is using RPLND to manage stage IIA/B at their institutions? What is your criteria for patient selection? How do you balance decision with other effective options (chemo/rads)? #SUO24 #richmatulewicz #timmasterson @samfunt.bsky.social
Prevention is a critical part of oncologic care. Appreciate Rich Matulewicz from MSK and Marc Bjurlin @uncchapelhill.bsky.social leading session on smoking cessation today. Great and practical recommendations #SUO24
December 4, 2024 at 9:32 PM
Prevention is a critical part of oncologic care. Appreciate Rich Matulewicz from MSK and Marc Bjurlin @uncchapelhill.bsky.social leading session on smoking cessation today. Great and practical recommendations #SUO24
Great to see my good friend and former SUO fellow Fed Ghali @uwmedicine.bsky.social @fredhutch.bsky.social on the stage! Should we be offering cystectomy in metastatic bladder cancer? Benefit likely in palliation but will this change as systemic therapies improve? #SUO24 @yalemedicine.bsky.social
December 4, 2024 at 8:12 PM
Great to see my good friend and former SUO fellow Fed Ghali @uwmedicine.bsky.social @fredhutch.bsky.social on the stage! Should we be offering cystectomy in metastatic bladder cancer? Benefit likely in palliation but will this change as systemic therapies improve? #SUO24 @yalemedicine.bsky.social
Does adjuvant radiotherapy have a role in urothelial carcinoma? Appreciate the talk by @fredhutch.bsky.social scientist and rad onc @omarmian.bsky.social. Benefit likely in high risk pts and risks lower with IMRT. Expect good discussion on this topic during Q&A.
December 4, 2024 at 7:41 PM
Does adjuvant radiotherapy have a role in urothelial carcinoma? Appreciate the talk by @fredhutch.bsky.social scientist and rad onc @omarmian.bsky.social. Benefit likely in high risk pts and risks lower with IMRT. Expect good discussion on this topic during Q&A.
An update on adjuvant therapies for high risk localized urothelial carcinoma by Dr. Jeannie Hoffman-Censits @johnshopkins.bsky.social. Improve DFS, OS benefit TBD. Harms are overtreatment and toxicity #SUO24
December 4, 2024 at 7:18 PM
An update on adjuvant therapies for high risk localized urothelial carcinoma by Dr. Jeannie Hoffman-Censits @johnshopkins.bsky.social. Improve DFS, OS benefit TBD. Harms are overtreatment and toxicity #SUO24
Excited to kickoff this years #SUO24 meeting with my co-chair Amy Luckenbaugh! We are excited to present a diverse and exciting program at this years meeting @danlinmd.bsky.social
December 4, 2024 at 7:05 PM
Excited to kickoff this years #SUO24 meeting with my co-chair Amy Luckenbaugh! We are excited to present a diverse and exciting program at this years meeting @danlinmd.bsky.social
First post on Bluesky and couldn’t be happier to have it be this. Thanks @loebstacy.bsky.social for visiting us at UW urology and for humoring me during our tour of Pike Place market. You have been an important role model for me and I’m looking forward to future collab
November 21, 2024 at 6:04 PM
First post on Bluesky and couldn’t be happier to have it be this. Thanks @loebstacy.bsky.social for visiting us at UW urology and for humoring me during our tour of Pike Place market. You have been an important role model for me and I’m looking forward to future collab